1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Partner Investment Management, L.P. Buys Stryker Corp, Allergan PLC, WellCare Health Plans Inc, Sells Unity Biotechnology Inc, Allakos Inc, Neon Therapeutics Inc

San Francisco, CA, based Investment company Partner Investment Management, L.P. buys Stryker Corp, Allergan PLC, WellCare Health Plans Inc, Pfizer Inc, UnitedHealth Group Inc, Puma Biotechnology Inc, New York Times Co, NXP Semiconductors NV, Aptiv PLC, Netflix Inc, Live Nation Entertainment Inc, Zimmer Biomet Holdings Inc, ICU Medical Inc, Sea, Fair Isaac Corp, PerkinElmer Inc, IQVIA Holdings Inc, Exact Sciences Corp, Ctrip.com International, Agilent Technologies Inc, PTC Therapeutics Inc, Splunk Inc, Square Inc, WAVE Life Sciences, Molina Healthcare Inc, Alder BioPharmaceuticals Inc, Lyft Inc, Dermira Inc, uniQure NV, Voyager Therapeutics Inc, Fluidigm Corp, Alibaba Group Holding, Nevro Corp, Shopify Inc, Merit Medical Systems Inc, Coherus BioSciences Inc, Mirati Therapeutics Inc, Zai Lab, sells Unity Biotechnology Inc, Allakos Inc, Neon Therapeutics Inc, BlackRock Inc, Abbott Laboratories, GoDaddy Inc, Salesforce.com Inc, Amazon.com Inc, CME Group Inc, Alphabet Inc, Microsoft Corp, Spark Therapeutics Inc, Aerie Pharmaceuticals Inc, Aptinyx Inc, PayPal Holdings Inc, Cigna Corp, DaVita Inc, Edwards Lifesciences Corp, Tableau Software Inc, Anthem Inc, AnaptysBio Inc, Sage Therapeutics Inc, Penumbra Inc, Blueprint Medicines Corp, Solid Biosciences Inc, Esperion Therapeutics Inc, Cardiovascular Systems Inc, Green Dot Corp, ServiceNow Inc, HCA Healthcare Inc, Pivotal Software Inc, LiveRamp Holdings Inc, Acorda Therapeutics Inc, Wright Medical Group NV, Kura Oncology Inc, Audentes Therapeutics Inc, Coupa Software Inc, Elastic NV, Pacira BioSciences Inc, ViewRay Inc, argenx SE, Carbon Black Inc, Fate Therapeutics Inc, Gritstone Oncology Inc, Zscaler Inc, Accuray Inc, StoneCo, Avrobio Inc, DocuSign Inc, Anaplan Inc, Arcus Biosciences Inc, Ascendis Pharma A/S, Marinus Pharmaceuticals Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Partner Investment Management, L.P.. As of 2019Q1, Partner Investment Management, L.P. owns 78 stocks with a total value of $70 million. These are the details of the buys and sells.

For the details of Partner Investment Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/partner+investment+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of Partner Investment Management, L.P.
  1. Microchip Technology Inc (MCHP) - 31,111 shares, 3.71% of the total portfolio. Shares added by 15.33%
  2. GoDaddy Inc (GDDY) - 32,538 shares, 3.52% of the total portfolio. Shares reduced by 42.44%
  3. Zimmer Biomet Holdings Inc (ZBH) - 19,030 shares, 3.49% of the total portfolio. Shares added by 50.45%
  4. Neon Therapeutics Inc (NTGN) - 359,125 shares, 3.33% of the total portfolio. Shares reduced by 56.85%
  5. Stryker Corp (SYK) - 11,607 shares, 3.30% of the total portfolio. New Position
New Purchase: Stryker Corp (SYK)

Partner Investment Management, L.P. initiated holding in Stryker Corp. The purchase prices were between $152.46 and $198, with an estimated average price of $179.51. The stock is now traded at around $185.67. The impact to a portfolio due to this purchase was 3.3%. The holding were 11,607 shares as of .

New Purchase: Allergan PLC (AGN)

Partner Investment Management, L.P. initiated holding in Allergan PLC. The purchase prices were between $132.09 and $160.79, with an estimated average price of $144.95. The stock is now traded at around $136.71. The impact to a portfolio due to this purchase was 2.42%. The holding were 11,505 shares as of .

New Purchase: WellCare Health Plans Inc (WCG)

Partner Investment Management, L.P. initiated holding in WellCare Health Plans Inc. The purchase prices were between $230.61 and $282.5, with an estimated average price of $258.4. The stock is now traded at around $272.85. The impact to a portfolio due to this purchase was 2.27%. The holding were 5,866 shares as of .

New Purchase: Puma Biotechnology Inc (PBYI)

Partner Investment Management, L.P. initiated holding in Puma Biotechnology Inc. The purchase prices were between $20.35 and $42.37, with an estimated average price of $30.25. The stock is now traded at around $16.59. The impact to a portfolio due to this purchase was 1.53%. The holding were 27,493 shares as of .

New Purchase: NXP Semiconductors NV (NXPI)

Partner Investment Management, L.P. initiated holding in NXP Semiconductors NV. The purchase prices were between $71.97 and $97.14, with an estimated average price of $87.6. The stock is now traded at around $100.17. The impact to a portfolio due to this purchase was 1.45%. The holding were 11,400 shares as of .

New Purchase: Aptiv PLC (APTV)

Partner Investment Management, L.P. initiated holding in Aptiv PLC. The purchase prices were between $60.42 and $84.27, with an estimated average price of $76.59. The stock is now traded at around $75.04. The impact to a portfolio due to this purchase was 1.41%. The holding were 12,375 shares as of .

Added: Pfizer Inc (PFE)

Partner Investment Management, L.P. added to a holding in Pfizer Inc by 194.80%. The purchase prices were between $39.53 and $43.65, with an estimated average price of $42.24. The stock is now traded at around $41.15. The impact to a portfolio due to this purchase was 2.05%. The holding were 50,864 shares as of .

Added: UnitedHealth Group Inc (UNH)

Partner Investment Management, L.P. added to a holding in UnitedHealth Group Inc by 94.13%. The purchase prices were between $236.02 and $271.13, with an estimated average price of $255.35. The stock is now traded at around $236.08. The impact to a portfolio due to this purchase was 1.56%. The holding were 9,035 shares as of .

Added: New York Times Co (NYT)

Partner Investment Management, L.P. added to a holding in New York Times Co by 150.55%. The purchase prices were between $21.39 and $34.49, with an estimated average price of $29.46. The stock is now traded at around $33.78. The impact to a portfolio due to this purchase was 1.48%. The holding were 52,307 shares as of .

Added: Live Nation Entertainment Inc (LYV)

Partner Investment Management, L.P. added to a holding in Live Nation Entertainment Inc by 691.82%. The purchase prices were between $47.69 and $64.28, with an estimated average price of $56.55. The stock is now traded at around $64.32. The impact to a portfolio due to this purchase was 1.29%. The holding were 16,256 shares as of .

Added: Zimmer Biomet Holdings Inc (ZBH)

Partner Investment Management, L.P. added to a holding in Zimmer Biomet Holdings Inc by 50.45%. The purchase prices were between $100.43 and $129.56, with an estimated average price of $116.76. The stock is now traded at around $118.55. The impact to a portfolio due to this purchase was 1.17%. The holding were 19,030 shares as of .

Added: ICU Medical Inc (ICUI)

Partner Investment Management, L.P. added to a holding in ICU Medical Inc by 139.40%. The purchase prices were between $221.09 and $253.28, with an estimated average price of $239.82. The stock is now traded at around $225.27. The impact to a portfolio due to this purchase was 1.1%. The holding were 5,499 shares as of .

Sold Out: Allakos Inc (ALLK)

Partner Investment Management, L.P. sold out a holding in Allakos Inc. The sale prices were between $33.79 and $52.27, with an estimated average price of $40.54.

Sold Out: BlackRock Inc (BLK)

Partner Investment Management, L.P. sold out a holding in BlackRock Inc. The sale prices were between $377.98 and $443.77, with an estimated average price of $419.31.

Sold Out: Abbott Laboratories (ABT)

Partner Investment Management, L.P. sold out a holding in Abbott Laboratories. The sale prices were between $66.22 and $80.06, with an estimated average price of $74.34.

Sold Out: CME Group Inc (CME)

Partner Investment Management, L.P. sold out a holding in CME Group Inc. The sale prices were between $162.58 and $188.12, with an estimated average price of $177.05.

Sold Out: Aerie Pharmaceuticals Inc (AERI)

Partner Investment Management, L.P. sold out a holding in Aerie Pharmaceuticals Inc. The sale prices were between $36.1 and $49.25, with an estimated average price of $43.86.

Sold Out: Cigna Corp (CI)

Partner Investment Management, L.P. sold out a holding in Cigna Corp. The sale prices were between $159.69 and $199.81, with an estimated average price of $183.17.



Here is the complete portfolio of Partner Investment Management, L.P.. Also check out:

1. Partner Investment Management, L.P.'s Undervalued Stocks
2. Partner Investment Management, L.P.'s Top Growth Companies, and
3. Partner Investment Management, L.P.'s High Yield stocks
4. Stocks that Partner Investment Management, L.P. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK